Inhibition of entire myelin basic protein‐induced experimental autoimmune encephalomyelitis in Lewis rats by major histocompatibility complex class II‐binding competitor peptides

摘要

AbstractPrevious studies have shown that major histocompatibility complex (MHC) blockade by competitor peptides with high MHC class II binding affinity can prevent peptide‐induced experimental autoimmune encephalomyelitis (EAE). However, none of these studies addressed the question whether this approach could also be used to prevent EAE induced with a multivalent antigen. In this report we show the effect of competitor peptides co‐immunized during EAE induction with entire guinea pig myelin basic protein (MBP) in Lewis rats. As MHC class II binding competitor peptides we used one nonimmunogenic disease‐nonrelated peptide, and two immunogenic peptides, one EAE‐related and one non‐EAE‐related. The respective efficacy of these three competitor peptides to inhibit MBP‐induced proliferation of an encephalitogenic T cell linein vitrocorrelated with their respective MHC binding affinity. Co‐immunization of the competitor peptides during disease induction with entire MBP resulted in a competitor concentration‐dependent inhibition of clinical signs of EAE. These results demonstrate that, although polyclonal T cell responses to MBP were not completely inhibited, co‐administration of immunogenic or nonimmunogenic either EAE‐related or non‐EAE‐related MHC class II binding competitor peptides can inhibit the development of EA